Effect of a novel vital sign device on maternal mortality and morbidity in low-resource settings: a pragmatic, stepped-wedge, cluster-randomised controlled trial.

ABSTRACT:

Background

In 2015, an estimated 303 000 women died in pregnancy and childbirth. Obstetric haemorrhage, sepsis, and hypertensive disorders of pregnancy account for more than 50% of maternal deaths worldwide. There are effective treatments for these pregnancy complications, but they require early detection by measurement of vital signs and timely administration to save lives. The primary aim of this trial was to determine whether implementation of the CRADLE Vital Sign Alert and an education package into community and facility maternity care in low-resource settings could reduce a composite of all-cause maternal mortality or major morbidity (eclampsia and hysterectomy).

Methods

We did a pragmatic, stepped-wedge, cluster-randomised controlled trial in ten clusters across Afric

SUBMITTER: Vousden N 

PROVIDER: S-EPMC6379820 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature